scholarly article | Q13442814 |
P356 | DOI | 10.1371/JOURNAL.PMED.1002184 |
P8608 | Fatcat ID | release_fpypazb5kzewzpiljvlwgknnsa |
P932 | PMC publication ID | 5127510 |
P698 | PubMed publication ID | 27898664 |
P50 | author | Andrew Stewardson | Q42862121 |
Stephan Harbarth | Q63391550 | ||
P2093 | author name string | Marlieke E A de Kraker | |
P2860 | cites work | Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe | Q28477449 |
The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study | Q37205523 | ||
Benchmarking the incidence and mortality of severe sepsis in the United States | Q45240119 | ||
Comparative cost of selective screening to prevent transmission of methicillin-resistant Staphylococcus aureus (MRSA), compared with the attributable costs of MRSA infection. | Q50791978 | ||
Hospital-acquired infections--appropriate statistical treatment is urgently needed! | Q51163990 | ||
Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. | Q51241980 | ||
The cost of antibiotic resistance: effect of resistance among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudmonas aeruginosa on length of hospital stay | Q77762612 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibiotic resistance | Q380775 |
multiple drug resistance | Q643839 | ||
antimicrobial resistance | Q63391344 | ||
P304 | page(s) | e1002184 | |
P577 | publication date | 2016-11-01 | |
P1433 | published in | PLOS MEDICINE | Q1686921 |
P1476 | title | Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? | |
P478 | volume | 13 |
Q64898179 | A Genomic, Evolutionary, and Mechanistic Study of MCR-5 Action Suggests Functional Unification across the MCR Family of Colistin Resistance. |
Q49588634 | A crucial list of pathogens |
Q57288616 | A microsimulation model projecting the health care costs for resistance to antibacterial drugs in Sweden |
Q61815779 | Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro |
Q52657335 | Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries. |
Q92814458 | Antibacterial Activity of Colloidal Silver against Gram-Negative and Gram-Positive Bacteria |
Q89720702 | Antibacterial activities of the extracts, fractions and isolated compounds from Canarium patentinervium Miq. against bacterial clinical isolates |
Q91853420 | Antibiotic resistance, stewardship, and consumption |
Q39168776 | Antimicrobial Dendrimeric Peptides: Structure, Activity and New Therapeutic Applications |
Q66679626 | Antimicrobial Gold Nanoclusters: Recent Developments and Future Perspectives |
Q89860099 | Antimicrobial Peptides: Virulence and Resistance Modulation in Gram-Negative Bacteria |
Q90584464 | Antimicrobial peptides: new hope in the war against multidrug resistance |
Q39311394 | Antimicrobial resistance: The complex challenge of measurement to inform policy and the public |
Q88257618 | Antimicrobial resistance: an urgent need for a planetary and ecosystem approach |
Q60124362 | Application of dynamic modelling techniques to the problem of antibacterial use and resistance: a scoping review |
Q60956911 | Applications of Noble Metal-Based Nanoparticles in Medicine |
Q64091723 | Assessment of knowledge and attitude trends towards antimicrobial resistance (AMR) among the community members, pharmacists/pharmacy owners and physicians in district Sialkot, Pakistan |
Q58611181 | Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis |
Q58571995 | Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles |
Q94545226 | Cell-Free DNA: An Underestimated Source of Antibiotic Resistance Gene Dissemination at the Interface Between Human Activities and Downstream Environments in the Context of Wastewater Reuse |
Q58772256 | Challenges in identifying antibiotic resistance targets for point-of-care diagnostics in general practice |
Q92494183 | Characterization of Biological Resistance and Successful Drug Resistance Control in Medicine |
Q51745780 | Characterization of the Lytic Capability of a LysK-Like Endolysin, Lys-phiSA012, Derived from a Polyvalent Staphylococcus aureus Bacteriophage. |
Q92784032 | Chloramphenicol Resurrected: A Journey from Antibiotic Resistance in Eye Infections to Biofilm and Ocular Microbiota |
Q64269492 | Communicating antimicrobial resistance and stewardship in the national press: Lessons from sepsis awareness campaigns |
Q92110552 | Communication strategies for improving public awareness on appropriate antibiotic use: Bridging a vital gap for action on antibiotic resistance |
Q59521527 | Converging and emerging threats to health security |
Q64291023 | Current accounts of antimicrobial resistance: stabilisation, individualisation and antibiotics as infrastructure |
Q64936972 | Definition of a Family of Nonmobile Colistin Resistance (NMCR-1) Determinants Suggests Aquatic Reservoirs for MCR-4. |
Q91631789 | Detection of antibiotic-resistant bacteria and their resistance genes from houseflies |
Q90404446 | Development of a Robust and Quantitative High-Throughput Screening Method for Antibiotic Production in Bacterial Libraries |
Q47765000 | Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. |
Q89600901 | ESKAPE Bacteria and Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolated from Wastewater and Process Water from German Poultry Slaughterhouses |
Q63400182 | Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study |
Q50041908 | Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model |
Q53689673 | Estimating the burden of antimicrobial resistance: a systematic literature review. |
Q90925083 | Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study |
Q38599622 | Evaluating the Clinical Burden and Mortality Attributable to Antibiotic Resistance: The Disparity of Empirical Data and Simple Model Estimations |
Q96123202 | Expanding the spectrum of antibiotics capable of killing multi-drug resistant Staphylococcus aureus and Pseudomonas aeruginosa |
Q89338599 | Extremely and pandrug-resistant bacteria extra-deaths: myth or reality? |
Q92639604 | Filling the gaps in global antimicrobial resistance research/surveillance |
Q57421040 | Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories |
Q60947141 | Genome Mining of sp. YIM 130001 Isolated From Lichen Affords New Thiopeptide Antibiotic |
Q90086365 | Health Professions Digital Education on Antibiotic Management: Systematic Review and Meta-Analysis by the Digital Health Education Collaboration |
Q92471376 | Health and economic burden of antimicrobial-resistant infections in Australian hospitals: a population-based model |
Q92637163 | Healthcare Associated Infections: An Interoperable Infrastructure for Multidrug Resistant Organism Surveillance |
Q90194136 | High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico |
Q64979127 | Hospitalisations with infections related to antimicrobial-resistant bacteria from the French nationwide hospital discharge database, 2016. |
Q54985894 | Human Activity Determines the Presence of Integron-Associated and Antibiotic Resistance Genes in Southwestern British Columbia. |
Q57664374 | Hydroxybenzylidene-indolinones, c-di-AMP synthase inhibitors, have antibacterial and anti-biofilm activities and also re-sensitize resistant bacteria to methicillin and vancomycin |
Q123351349 | Identification of a Family of Glycoside Derivatives Biologically Active against Acinetobacter baumannii and Other MDR Bacteria Using a QSPR Model |
Q64964600 | Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1). |
Q92707025 | Improving the estimation of the global burden of antimicrobial resistant infections |
Q92663733 | In Silico and In Vitro Experimental Studies of New Dibenz[b,e]oxepin-11(6H)one O-(arylcarbamoyl)-oximes Designed as Potential Antimicrobial Agents |
Q92437903 | Indole hybridized diazenyl derivatives: synthesis, antimicrobial activity, cytotoxicity evaluation and docking studies |
Q57807508 | Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories |
Q88508228 | Keeping the faith - reporting on antimicrobial resistance in an era of fake news |
Q53742314 | Keeping the faith-reporting on antimicrobial resistance in an era of fake news. |
Q90696464 | Low incidence of antibiotic-resistant bacteria in south-east Sweden: An epidemiologic study on 9268 cases of bloodstream infection |
Q101237290 | Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strains |
Q92854535 | Mesoporous Silica Nanoparticles for the Treatment of Complex Bone Diseases: Bone Cancer, Bone Infection and Osteoporosis |
Q90356059 | Mixed-charge pseudo-zwitterionic mesoporous silica nanoparticles with low-fouling and reduced cell uptake properties |
Q92875295 | Mobilizable antibiotic resistance genes are present in dust microbial communities |
Q97644491 | Mobilization of Antibiotic Resistance: Are Current Approaches for Colocalizing Resistomes and Mobilomes Useful? |
Q90261518 | Molecular and Microbial Microenvironments in Chronically Diseased Lungs Associated with Cystic Fibrosis |
Q90264432 | No global increase in resistance to antibiotics: a snapshot of resistance from 2001 to 2016 in Marseille, France |
Q57130953 | Non-Antimicrobial Drugs: Etodolac as a Possible Antimicrobial or Adjuvant Agent Against ESKAPE Pathogens |
Q91742543 | Novel antibiotics effective against gram-positive and -negative multi-resistant bacteria with limited resistance |
Q41109803 | Pandemics, public health emergencies and antimicrobial resistance - putting the threat in an epidemiologic and risk analysis context |
Q59128002 | Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials |
Q99588371 | Phyto-nano-hybrids of Ag-CuO particles for antibacterial activity against drug-resistant pathogens |
Q100472430 | Phytochemical conjugation as a potential semisynthetic approach toward reactive and reuse of obsolete sulfonamides against pathogenic bacteria |
Q99580010 | Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance |
Q90220917 | Prescription of antibiotics after tooth extraction in adults: a nationwide study in Korea |
Q95601126 | Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention |
Q58611182 | Public health burden of antimicrobial resistance in Europe |
Q90079603 | Quantifying the economic cost of antibiotic resistance and the impact of related interventions: rapid methodological review, conceptual framework and recommendations for future studies |
Q91650831 | Quantifying uncertainty about future antimicrobial resistance: Comparing structured expert judgment and statistical forecasting methods |
Q64120325 | Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains |
Q64239746 | Rapid molecular detection of macrolide resistance |
Q64986806 | Resistance proportions for eight priority antibiotic-bacterium combinations in OECD, EU/EEA and G20 countries 2000 to 2030: a modelling study. |
Q98290025 | Sale of WHO AWaRe groups antibiotics without a prescription in Pakistan: a simulated client study |
Q102221234 | Semi-synthetic vitamin E derivatives as potent antibacterial agents against resistant Gram-positive pathogens |
Q89554294 | Social science research contributions to antimicrobial resistance: protocol for a scoping review |
Q90643404 | Spread of MCR-3 Colistin Resistance in China: An Epidemiological, Genomic and Mechanistic Study |
Q90968488 | Standardising the reporting of microbiology and antimicrobial susceptibility data |
Q46268910 | Surveillance for control of antimicrobial resistance |
Q64465697 | Suspended Materials in River Waters Differentially Enrich Class 1 Integron- and IncP-1 Plasmid-Carrying Bacteria in Sediments |
Q57174160 | Tackling the Antibiotic Resistance Caused by Class A -Lactamases through the Use of -Lactamase Inhibitory Protein |
Q92404364 | The Anti-virulence Efficacy of 4-(1,3-Dimethyl-2,3-Dihydro-1H-Benzimidazol-2-yl)Phenol Against Methicillin-Resistant Staphylococcus aureus |
Q90024194 | The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort study |
Q100634197 | The safety profile of Bald's eyesalve for the treatment of bacterial infections |
Q90264507 | Transmission Routes of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in a Neonatology Ward in Madagascar |
Q90458303 | Trends and impact of antimicrobial resistance on older inpatients with urinary tract infections (UTIs): A national retrospective observational study |
Q89692180 | Underrated Staphylococcus species and their role in antimicrobial resistance spreading |
Q47606815 | Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance |
Q61801525 | Using the best available data to estimate the cost of antimicrobial resistance: a systematic review |
Q61444724 | Virulence Characteristics and an Action Mode of Antibiotic Resistance in Multidrug-Resistant Pseudomonas aeruginosa |
Q57835596 | Where Did They Come from-Multi-Drug Resistant Pathogenic in a Cemetery Environment? |
Q90295102 | [Infections due to multidrug-resistant pathogens : Pathogens, resistance mechanisms and established treatment options] |
Search more.